Cervical Adenopathy

Evaluating persistent cervical adenopathy in adults requires a systematic approach to differentiate between various etiologies, ranging from common infections to malignancy. Begin with a thorough history, focusing on symptom duration, associated symptoms (e.g., fever, night sweats, weight loss), exposure history (e.g., travel, sick contacts, animal bites), and relevant past medical history. Physical examination should assess the size, consistency, mobility, and tenderness of the lymph nodes, as well as examination of the head and neck, including the oropharynx and skin. Initial laboratory investigations may include a complete blood count (CBC) with differential, inflammatory markers (e.g., erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]), and serological tests for infectious diseases based on clinical suspicion (e.g., Epstein-Barr virus [EBV], cytomegalovirus [CMV], toxoplasmosis). Imaging studies, such as ultrasound or CT scan of the neck, can further characterize the adenopathy and identify other abnormalities. Fine-needle aspiration biopsy (FNAB) or excisional biopsy should be considered for persistent or suspicious adenopathy, particularly if accompanied by concerning features like rapid growth, firmness, fixation, or systemic symptoms. Consider implementing a tiered approach to diagnostics based on initial findings, reserving more invasive procedures for cases with higher suspicion of malignancy. Explore how point-of-care ultrasound can be integrated into initial assessment to expedite the diagnosis of cervical adenopathy. Learn more about specific diagnostic criteria for different causes of lymphadenopathy.

Urgent referral for suspected cervical lymphadenopathy is warranted when red flag symptoms raise concern for malignancy or a serious underlying condition. These red flags include rapid growth, firm or hard consistency, fixation to surrounding tissues, supraclavicular location, constitutional symptoms (e.g., unexplained fever, night sweats, weight loss exceeding 10% of body weight in 6 months), dysphagia, hoarseness, or persistent unilateral adenopathy. In addition, clinicians should consider urgent referral for patients with significant pain or discomfort associated with the adenopathy, especially if accompanied by erythema, warmth, or fluctuance, suggesting possible abscess formation. A comprehensive history and physical examination are crucial to identify these red flags. Consider implementing a standardized checklist for evaluating cervical lymphadenopathy to ensure consistent and thorough assessment. Learn more about current guidelines for managing head and neck masses.

Differentiating reactive from malignant cervical lymphadenopathy relies on a combination of clinical and diagnostic findings. Reactive lymphadenopathy often presents with tender, mobile, soft to rubbery nodes, typically associated with an identifiable infection or inflammatory process. Malignant lymphadenopathy, conversely, tends to be characterized by painless, firm, fixed, or matted nodes, often accompanied by constitutional symptoms. Size can be helpful, but is not always definitive; while larger nodes may raise suspicion for malignancy, reactive nodes can also be significantly enlarged. Diagnostic workup includes blood tests (CBC, inflammatory markers), imaging (ultrasound, CT), and potentially FNAB or excisional biopsy. The characteristics of the aspirate or biopsy specimen, evaluated by a pathologist, are crucial for distinguishing between benign and malignant processes. Explore how advanced imaging techniques, such as PET-CT, can be utilized in cases with high suspicion of malignancy. Consider implementing a multidisciplinary approach involving hematologists or oncologists for complex cases of cervical adenopathy.